Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

Cardiol Therapeutics Inc. received over USD $7 million from the exercise of common share purchase warrants. The funds will extend the cash runway and support operations for the pivotal Phase III MAVERIC trial.

PUBLIC · CRDLSep 16, 2026•about 3 hours ago

Amount Raised

$7 Million

Round Type

Venture - Series Unknown

OakvilleBiotechnologyHealthcare

Description

Cardiol Therapeutics Inc. has announced proceeds of over USD $7 million from the exercise of outstanding common share purchase warrants. The capital raised will extend Cardiol's cash runway into H1 2028 and fund operations for the pivotal Phase III MAVERIC trial. This reflects shareholders' confidence in the company's clinical progress and long-term potential

Company Information

Company

Cardiol Therapeutics Inc.

Location

2275 UPPER MIDDLE ROAD EAST, STE. 101

Oakville, Iowa, United States

About

A biotechnology company.

Don't miss Cardiol Therapeutics Inc.'s next move

Get an email the moment Cardiol Therapeutics Inc. raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Cardiol Therapeutics Inc.'s next move

See what Strategic adds

Cardiol Therapeutics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.